These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26968400)

  • 41. Transfusion-transmitted cytomegalovirus: the part-time pathogen.
    Gunter KC
    Pediatr Pathol Lab Med; 1995; 15(3):515-34. PubMed ID: 8597838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Window period donations during primary cytomegalovirus infection and risk of transfusion-transmitted infections.
    Ziemann M; Heuft HG; Frank K; Kraas S; Görg S; Hennig H
    Transfusion; 2013 May; 53(5):1088-94. PubMed ID: 23320406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
    Das B; Kaur G; Basu S
    Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of transfusion-associated cytomegalovirus (CMV) infection in neonates by screening blood donors for IgM to CMV.
    Lamberson HV; McMillian JA; Weiner LB; Williams ML; Clark DA; McMahon CA; Lentz EB; Higgins AP; Dock NL
    J Infect Dis; 1988 Apr; 157(4):820-3. PubMed ID: 2831288
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experiences with transfusion of CMV tested blood preparations after bone marrow transplantation].
    Luboldt W; Henneberg-Quester KB; Schaefer UW; Beelen DW; Quabeck K; Thraenhart O
    Beitr Infusionsther; 1990; 26():190-3. PubMed ID: 1703827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of difference in cytomegalovirus transmission via the transfusion of filtered-irradiated and nonfiltered-irradiated blood to newborn infants in an endemic area.
    Ohto H; Ujiie N; Hirai K
    Transfusion; 1999 Feb; 39(2):201-5. PubMed ID: 10037132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital cytomegalovirus infection as a preventable complication of maternal transfusion. A case report.
    McGregor JA; Rubright G; Ogle JW
    J Reprod Med; 1990 Jan; 35(1):61-4. PubMed ID: 2153814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfusion-transmitted cytomegalovirus: lessons from a murine model.
    Roback JD; Su L; Zimring JC; Hillyer CD
    Transfus Med Rev; 2007 Jan; 21(1):26-36. PubMed ID: 17174218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. To filter blood or universal leukoreduction: what is the answer?
    Shapiro MJ
    Crit Care; 2004; 8 Suppl 2(Suppl 2):S27-30. PubMed ID: 15196319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
    Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
    Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy.
    Yinon Y; Farine D; Yudin MH
    Obstet Gynecol Surv; 2010 Nov; 65(11):736-43. PubMed ID: 21375790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
    Milbradt H; Flik J; Stangel W; Heigel R
    Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfusion and cytomegalovirus-associated AIDS-defining disease in hemophiliacs. Hemophilia Malignancy Study.
    Ragni MV; Triulzi DJ; Bass D; Duerstein S
    Transfusion; 1996 Aug; 36(8):681-4. PubMed ID: 8780661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reducing the risk for transfusion-transmitted cytomegalovirus infection.
    Sayers MH; Anderson KC; Goodnough LT; Kurtz SR; Lane TA; Pisciotto P; Silberstein LE
    Ann Intern Med; 1992 Jan; 116(1):55-62. PubMed ID: 1309201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The prevention of cytomegalovirus infection and disease by administration of biological products].
    Ihara T
    Nihon Rinsho; 1998 Jan; 56(1):145-50. PubMed ID: 9465680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transfusion-acquired cytomegalovirus infection in cardiac surgery patients.
    Preiksaitis JK; Grumet FC; Smith WK; Merigan TC
    J Med Virol; 1985 Mar; 15(3):283-90. PubMed ID: 2984327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.